RenovoRx, Inc. (RNXT) Reports Q1 Loss, Tops Revenue Estimates

RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.08 per share a year ago.